- 全部删除
- 您的购物车当前为空
LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1].
LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 3,126 | 期货 | |
10 mg | ¥ 5,030 | 期货 | |
25 mg | ¥ 10,092 | 期货 |
产品描述 | LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1]. |
体外活性 | LSD1/HDAC6-IN-1 shows superior potency in multiple MM lines[1]. |
体内活性 | LSD1/HDAC6-IN-1 is efficacy in the MM.1S xenograft model[1]. |
别名 | LSD1/HDAC6-IN-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容